Ionis Pharmaceuticals IONS Diluted (in shares)
Diluted (in shares) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's diluted (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's diluted (in shares)?
- Ionis Pharmaceuticals (IONS) reported diluted (in shares) of $164.87M in Q1 2026.
- How has Ionis Pharmaceuticals's diluted (in shares) changed year-over-year?
- Ionis Pharmaceuticals's diluted (in shares) increased by 3.9% year-over-year, from $158.74M to $164.87M.
- What is the long-term trend for Ionis Pharmaceuticals's diluted (in shares)?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's diluted (in shares) has grown at a 3.2% compound annual growth rate (CAGR), from $583.21M to $660.84M.
- What does diluted (in shares) mean?
- The average number of shares outstanding during the period, adjusted to include the dilutive impact of all potential shares from convertible debt, options, and warrants. This figure is used to calculate diluted earnings per share.